株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

肺扁平上皮癌:世界の治験レビュー

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 304743
出版日 ページ情報 英文 161 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
肺扁平上皮癌:世界の治験レビュー Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
出版日: 2014年05月26日 ページ情報: 英文 161 Pages
概要

当レポートでは、肺扁平上皮癌に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 肺扁平上皮癌
  • 当レポートの概要

各地域における治験状況

各国の治験件数と平均被験者数

  • アジア太平洋地域の上位5ヶ国における治験件数
  • 欧州上位5ヶ国における治験件数
  • 北米の主要国における治験件数
  • 中東およびアフリカの主要国における治験件数
  • 中南米の上位5ヶ国における治験件数

G7諸国での治験件数:癌の治験件数に対する肺扁平上皮癌の比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7(新興7カ国)における治験件数:癌の治験件数に対する肺扁平上皮癌の比率

E7(新興7カ国)におけるフェーズ(相)別の治験件数

E7(新興7カ国)における進捗状況別の治験件数

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

未達成の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

最新の治験情報

治験のプロファイル

  • 代表的企業の治験の概要
    • F. Hoffmann-La Roche Ltd.
    • Eli Lilly and Company
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • AstraZeneca PLC
    • AbbVie Inc.
    • Novartis AG
    • GlaxoSmithKline plc
    • Debiopharm International S.A.
    • Agennix AG
  • 代表的な研究機関・病院の治験の概要
    • National Cancer Institute
    • Mayo Clinic
    • Cancer Institute Hospital Japanese Foundation for Cancer Research
    • Rigshospitalet
    • Sarah Cannon Research Institute
    • Wake Forest University
    • 広島大学病院
    • Eastern Cooperative Oncology Group
    • Samsung Medical Center

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2164CTIDB

GlobalData's clinical trial report, "Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Squamous Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Squamous Non-Small Cell Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Squamous Non-Small Cell Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Squamous Non-Small Cell Lung Cancer
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Squamous Non-Small Cell Lung Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Squamous Non-Small Cell Lung Cancer
    • Sep 09, 2013: Oncolytics Biotech Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN in Squamous Cell Lung Cancer
    • Aug 13, 2013: Eli Lilly and Company's Phase III study of necitumumab meets primary endpoint
    • Jun 04, 2013: Debiopharm Announces Additional Phase I Clinical Trial Evaluating Debio 1143 Combined With Chemotherapies For Patients With Selected Solid Malignancies
    • May 23, 2013: OncoGenex Pharma Announces Plans For Initiation Of Cedar Clinical Trial Evaluating OGX-427 In Combination With Chemotherapy In Advanced Squamous Cell Lung Cancer
    • Mar 28, 2013: Oncolytics Biotech Meets Primary Overall Statistical Endpoint In US Phase II Study Of Reolysin In Squamous Cell Lung Cancer
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Debiopharm International S.A.
      • Clinical Trial Overview of Debiopharm International S.A.
      • Agennix AG
      • Clinical Trial Overview of Agennix AG
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Cancer Institute Hospital Japanese Foundation for Cancer Research
      • Clinical Trial Overview of Cancer Institute Hospital Japanese Foundation for Cancer Research
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • Sarah Cannon Research Institute
      • Clinical Trial Overview of Sarah Cannon Research Institute
      • Wake Forest University
      • Clinical Trial Overview of Wake Forest University
      • Hiroshima University Hospital
      • Clinical Trial Overview of Hiroshima University Hospital
      • Eastern Cooperative Oncology Group
      • Clinical Trial Overview of Eastern Cooperative Oncology Group
      • Samsung Medical Center
      • Clinical Trial Overview of Samsung Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Squamous Non-Small Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Debiopharm International S.A., 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Agennix AG, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Institute Hospital Japanese Foundation for Cancer Research, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2014*

List of Figures

  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Squamous Non-Small Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Squamous Non-Small Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Squamous Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top